The Fort Worth Press - US panel weighs authorizing Covid vaccines for youngest children

USD -
AED 3.673042
AFN 64.000368
ALL 80.559269
AMD 363.520403
ANG 1.790365
AOA 918.000367
ARS 1524.747504
AUD 1.42296
AWG 1.80075
AZN 1.70397
BAM 1.714464
BBD 2.012413
BDT 122.948664
BGN 1.683441
BHD 0.376649
BIF 3009.415106
BMD 1
BND 1.276562
BOB 12.244898
BRL 5.200457
BSD 0.999106
BTN 95.679045
BWP 13.604786
BYN 3.018795
BYR 19600
BZD 2.00952
CAD 1.41513
CDF 2310.000362
CHF 0.82901
CLF 0.024368
CLP 962.203912
CNY 6.71135
CNH 6.723895
COP 3317.49
CRC 454.274493
CUC 1
CUP 23.978646
CVE 96.662634
CZK 21.385104
DJF 177.720393
DKK 6.56233
DOP 59.418613
DZD 133.781625
EGP 51.765104
ERN 15
ETB 162.087103
EUR 0.87782
FJD 2.24725
FKP 0.756753
GBP 0.754985
GEL 2.61504
GGP 0.756753
GHS 11.604951
GIP 0.756753
GMD 73.503851
GNF 8787.432499
GTQ 7.630269
GYD 209.052178
HKD 7.84427
HNL 26.817273
HRK 6.613904
HTG 130.75952
HUF 320.43604
IDR 17957
ILS 3.04806
IMP 0.756753
INR 95.742704
IQD 1308.910162
IRR 1374575.000352
ISK 120.270386
JEP 0.756753
JMD 158.069366
JOD 0.70904
JPY 157.288504
KES 129.530385
KGS 87.448204
KHR 4063.223227
KMF 433.00035
KPW 900.000318
KRW 1356.303789
KWD 0.30865
KYD 0.832592
KZT 442.57352
LAK 22411.284101
LBP 89473.841083
LKR 329.886786
LRD 171.856371
LSL 16.301459
LTL 2.95274
LVL 0.60489
LYD 6.387819
MAD 9.588067
MDL 17.734435
MGA 4411.249036
MKD 53.977298
MMK 2099.49869
MNT 3598.832458
MOP 8.072056
MRU 40.194433
MUR 47.530378
MVR 15.450378
MWK 1732.502279
MXN 17.71373
MYR 4.074204
MZN 63.910377
NAD 16.301459
NGN 1325.830377
NIO 36.766253
NOK 9.505075
NPR 153.086647
NZD 1.765675
OMR 0.384492
PAB 0.999106
PEN 3.391893
PGK 4.451574
PHP 62.345038
PKR 276.855854
PLN 3.83815
PYG 5889.262922
QAR 3.641998
RON 4.628604
RSD 103.164038
RUB 84.150357
RWF 1476.627731
SAR 3.749807
SBD 8.000512
SCR 13.951753
SDG 601.503676
SEK 9.91538
SGD 1.277495
SHP 0.755002
SLE 24.650371
SLL 20969.491881
SOS 571.04285
SRD 37.667504
STD 20697.981008
STN 21.477663
SVC 8.742724
SYP 13002.000254
SZL 16.297602
THB 33.377504
TJS 9.217161
TMT 3.51
TND 2.957752
TOP 2.40776
TRY 48.963404
TTD 6.795708
TWD 31.736404
TZS 2644.998038
UAH 44.740953
UGX 3913.317904
UYU 40.026123
UZS 11824.624919
VES 852.43145
VND 25976
VUV 118.506411
WST 2.765483
XAF 575.812448
XAG 0.015545
XAU 0.000233362426
XCD 2.70255
XCG 1.8005
XDR 0.707052
XOF 575.812448
XPF 104.548005
YER 236.650363
ZAR 16.31735
ZMK 9001.203584
ZMW 19.490322
ZWL 321.999592
SSP 5712.5919
MXV 2.007353
  • RIO

    -0.3300

    97.04

    -0.34%

  • CMSC

    -0.0400

    20.67

    -0.19%

  • RELX

    0.0000

    33.41

    0%

  • RBGPF

    0.0000

    67.95

    0%

  • BCE

    -0.0700

    21.99

    -0.32%

  • BCC

    -0.0300

    75.66

    -0.04%

  • GSK

    0.8600

    51.08

    +1.68%

  • JRI

    -0.0300

    11.52

    -0.26%

  • NGG

    -0.1200

    76.68

    -0.16%

  • CMSD

    0.0900

    20.54

    +0.44%

  • BTI

    -0.0800

    55.75

    -0.14%

  • AZN

    2.0200

    168.1

    +1.2%

  • BP

    -1.4200

    43.16

    -3.29%

  • RYCEF

    0.4600

    19.7

    +2.34%

  • VOD

    0.0700

    17.02

    +0.41%

US panel weighs authorizing Covid vaccines for youngest children
US panel weighs authorizing Covid vaccines for youngest children / Photo: © AFP/File

US panel weighs authorizing Covid vaccines for youngest children

After months of anxious wait for some parents, a panel of experts convened by the US Food and Drug Administration will meet Wednesday to weigh recommending Covid vaccines for the nation's youngest children.

Text size:

Children under five are the only age group not yet eligible for Covid immunization in the United States and most other countries. If, as expected, panelists vote in favor of greenlighting the Pfizer and Moderna vaccines, formal authorizations should follow quickly, with the first shots in arms expected by next week.

Ahead of the meeting, the FDA posted its independent analyses of the two drugs, deeming both safe and effective. It also said there was a pressing unmet need to inoculate children in the age group since their rates of hospitalization and death "are higher than among children and adolescents 5-17 years of age."

Both vaccines are based on messenger RNA technology, which delivers genetic code for the coronavirus spike protein to human cells, training the immune system to be ready for when it encounters the real virus.

Pfizer is seeking authorization for three doses at three micrograms given to ages six months through four years, while Moderna has asked for the FDA to approve its vaccine as two doses of a higher 30 micrograms, for ages six months through five years.

They were tested in trials of thousands of children where they were found to have similar levels of mild effects to older age groups and triggered similar levels of antibodies.

Efficacy against infection was higher for Pfizer, with the company placing it at 80 percent compared to Moderna's estimates of 51 percent in the six-month-old to age two group and 37 percent in the two to five years age group.

But the figures are provisional and Moderna is studying adding a third dose later that may increase its figures.

There are some 20 million US children aged four years and under. If the FDA-appointed experts recommend the two vaccines, then the matter will go to another committee convened by the Centers for Disease Control and Prevention for a final say.

White House officials last week said the rollout of millions of shots at pharmacies and doctors' offices could begin as soon as June 21, following the Juneteenth holiday on June 20.

Of the total US Covid deaths, 480 have come in children under five, according to the latest official data.

Obesity, neurological disorders and asthma are associated with increased risk of severe disease, "however, a majority of children hospitalized for Covid-19 have no underlying medical conditions," the FDA said in a document.

Children can also go on to contract multisystem inflammatory syndrome in children (MIS-C), a rare but serious post-viral condition.

Data on long Covid in children is sparse, but the FDA's document cited a national survey in the United Kingdom which found that "among children ages two to 11 years who tested positive for COVID-19, 7.2 percent reported continued symptoms at 12 weeks."

H.Carroll--TFWP